Craig Gilgallon
Founder at Cingulate Works, Inc.
Net worth: 8 183 $ as of 29/04/2024
Profile
Craig Steven Gilgallon is the founder of Cingulate Works, Inc. (founded in 2013) and Cingulate, Inc. (founded in 2013).
He held the titles of Secretary, Executive VP & General Counsel at both companies.
Mr. Gilgallon is also the founder of Cingulate Therapeutics LLC.
Mr. Gilgallon's current job is as a Partner at Pawar Gilgallon & Rudy LLC (since 2012).
Mr. Gilgallon's education history includes an undergraduate degree from Ithaca College and a graduate degree from Thomas Jefferson School of Law.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CINGULATE, INC.
0.24% | 14/04/2024 | 9,742 ( 0.24% ) | 8 183 $ | 29/04/2024 |
Craig Gilgallon active positions
Companies | Position | Start |
---|---|---|
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Founder | 31/12/2012 |
Pawar Gilgallon & Rudy LLC | Corporate Officer/Principal | 31/12/2011 |
Former positions of Craig Gilgallon
Companies | Position | End |
---|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Founder | 14/12/2023 |
CINGULATE INC. | Founder | 14/12/2023 |
Training of Craig Gilgallon
Ithaca College | Undergraduate Degree |
Thomas Jefferson School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CINGULATE INC. | Health Technology |
Private companies | 3 |
---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Pawar Gilgallon & Rudy LLC | |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
- Stock Market
- Insiders
- Craig Gilgallon